John Hovanesian, MD
Show Description +
John Hovanesian, MD, shares highlights from his presentation during the ASCRS annual meeting on managing ocular surface disease before cataract surgery. He specifically discusses the use of cyclosporine 0.09%, detailing the outcomes of a study in which 50 patients with dry eye were treated with the solution for 28 days.
Posted: 4/10/2024
John Hovanesian, MD
John Hovanesian, MD, shares highlights from his presentation during the ASCRS annual meeting on managing ocular surface disease before cataract surgery. He specifically discusses the use of cyclosporine 0.09%, detailing the outcomes of a study in which 50 patients with dry eye were treated with the solution for 28 days.
Posted: 4/10/2024
Bryn Mawr Communications, LLC, and Eyetube.net are not affiliated with the official program of ASCRS: 2024.
Please log in to leave a comment.